This researcher can't be held back.

Think of your immune system as a well-trained army. Some soldiers in this army (immune cells) are fierce fighters, attacking invaders like viruses or cancer cells, while others are peacekeepers, calming the fighting down to avoid collateral damage.

?

But what happens if the peacekeepers are too strong, holding back the soldiers who need to fight? This can happen with cancer, where the immune system’s peacekeepers (cells called Tregs) sometimes stop the immune soldiers (effector T cells) from attacking tumors effectively.

Researchers like the V Foundation grantee Dr. Jamie Spangler at The Johns Hopkins University have long been trying to boost the fighting side of the immune system using a molecule called interleukin-2, or IL-2, which acts like an energy drink for immune cells (like what my peach Monster does for me in the mornings). The problem? IL-2 powers up both the soldiers and the peacekeepers of the immune system, so it’s been hard to direct immune cell fighters to attack tumors without also activating too many immune cell peacekeepers, which can dampen the overall fight.

?

A very cool study from Dr. Spangler’s lab study shares a new tool the lab has created - a sophisticated molecule that acts like a guided missile for the immune system. Instead of powering up all immune cells, this molecule selectively targets the immune soldiers while holding back the peacekeepers. By fusing two molecules - one that blocks peacekeepers and another that boosts only the soldiers - this engineered molecule helps the immune system unleash its full attack power on cancer.

?

The coolest part? The Spangler lab designed the molecular tool in such a way that it sticks around in the body for a long time, avoiding the quick turnover that previous approaches faced. It’s like upgrading from a short-lived energy drink to a slow-release superfood that keeps your immune system energized for longer.

?

The impact of this study is huge for cancer patients. By making IL-2 more effective and safer, Dr. Spangler’s research could lead to new ways to treat cancers that involve the immune system, offering hope to patients who need better options.

?

This type of developmental research is crucial because it improves our understanding of how to fine-tune the immune system to target cancer cells, which could lead to even more effective therapies in the future.

?

Follow the Spangler lab here: https://doi.org/10.1172/jci.insight.173469 and read this cool paper at: https://www.spanglerlab.org/.